|1.||Spessotto, P: 1 article (06/2004)|
|2.||Zabucchi, G: 1 article (06/2004)|
|3.||Scarcia, V: 1 article (06/2004)|
|4.||Furlani, A: 1 article (06/2004)|
|5.||Podda, E: 1 article (06/2004)|
|6.||Cocchietto, M: 1 article (06/2004)|
|7.||Frausin, F: 1 article (06/2004)|
|8.||Sava, G: 1 article (06/2004)|
|9.||Vita, F: 1 article (06/2004)|
01/01/1989 - "Electron microscopic observations of HPMN that had taken up EB or EB cell walls demonstrated EB cell walls in the HPMN phagosomes at 24 h after infection. "
02/01/1991 - "In vitro models of Chlamydia trachomatis inhibition by cytokines, human-monocyte derived macrophages (HMDM) and human polymorphonuclear leukocytes (HPMN) are discussed in an attempt to delineate the molecular basis of parasite-host cell interplay in persistent and chronic chlamydial infection. "
01/01/1989 - "Analysis of extracts of the HPMN that had taken up either EB or EB cell walls on Urografin density gradients at 2 and 24 h after infection, and electron microscopic observations on fractions representing the peaks, demonstrated the persistence of the EB cell walls in the HPMN. "
01/01/1989 - "trachomatis EB and EB cell wall proteins extracted from the HPMN at 2 and 24 h after infection demonstrated the persistence of most of the chlamydial cell wall polypeptides. "
06/01/2004 - "Imidazolium trans-imidazoledimethylsulphoxidetrachlororuthenate (NAMI-A) was tested in vitro on the pro-adhesive properties, evaluated as resistance to trypsin treatment, which is a bona fide measure of adhesion strength, of KB and HeLa carcinoma cell lines and on human polymorphonuclear neutrophils (HPMN). "
|3.||Proteins (Proteins, Gene)
|5.||Diatrizoate Meglumine (Gastrograffin)
|6.||Opioid Analgesics (Opioids)
|7.||imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)